Vanguard Investments Australia’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$255K Hold
16,889
﹤0.01% 2001
2026
Q1
$324K Buy
+16,889
New +$367K ﹤0.01% 1802

Other funds holding TNDM

Vanguard Investments Australia's TNDM Position: Q2 2026 in Review

Vanguard Investments Australia held its Tandem Diabetes Care (TNDM) position steady in Q2 2026 at 16,889 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #2001.

Vanguard Investments Australia first reported a position in TNDM in Q1 2026 and has held it in 2 quarters since. The position peaked at $324K in Q1 2026. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Vanguard Investments Australia held 16,889 shares of Tandem Diabetes Care worth $255K as of Q2 2026.
  • Vanguard Investments Australia left its Tandem Diabetes Care share count unchanged in Q2 2026.
  • Tandem Diabetes Care made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #2001 holding.
  • Vanguard Investments Australia first reported a position in Tandem Diabetes Care in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Investments Australia's Tandem Diabetes Care position peaked at $324K in Q1 2026.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.